Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
InMed Pharmaceuticals (INM)
NASDAQ:INM
RESEARCH TOOLSreports
Holding INM?
Track your performance easily
| Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | |
|---|---|---|---|---|---|
| Income Statement | - | ||||
| Total Revenue | $ 1.26M | $ 1.28M | $ 1.17M | $ 1.24M | $ 901.86K |
| Gross Profit | $ 493.41K | $ 466.07K | $ 289.46K | $ 324.14K | $ 21.24K |
| EBIT | $ -1.68M | $ -1.93M | $ -1.72M | $ -1.48M | $ -2.54M |
| EBITDA | $ -1.53M | $ -1.78M | $ -1.57M | $ -1.33M | $ -2.39M |
| Net Income Common Stockholders | $ -1.68M | $ -1.94M | $ -1.72M | $ -1.48M | $ -2.54M |
| Balance Sheet | - | ||||
| Cash, Cash Equivalents and Short-Term Investments | $ 5.63M | $ 6.61M | $ 7.64M | $ 9.58M | $ 6.78M |
| Total Assets | $ 10.47M | $ 11.82M | $ 13.36M | $ 15.26M | $ 10.92M |
| Total Debt | $ 1.06M | $ 962.66K | $ 1.07M | $ 1.17M | $ 293.00K |
| Net Debt | $ -4.57M | $ -5.65M | $ -6.57M | $ -8.41M | $ -6.49M |
| Total Liabilities | $ 2.07M | $ 2.62M | $ 2.25M | $ 2.48M | $ 1.34M |
| Stockholders Equity | $ 8.40M | $ 9.21M | $ 11.10M | $ 12.77M | $ 9.58M |
| Cash Flow | - | ||||
| Free Cash Flow | $ -1.83M | $ -1.03M | - | - | - |
| Operating Cash Flow | $ -1.83M | $ -1.03M | $ -1.93M | $ -1.85M | $ -2.17M |
| Investing Cash Flow | - | - | $ -2.00 | $ -9.29K | - |
| Financing Cash Flow | $ 838.24K | $ 176.00 | - | $ 4.65M | - |
InMed Pharmaceuticals Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.